Joseph B Lillegard

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Gourish Mondal, Caitlin J VanLith, Clara T Nicolas, Whitney S Thompson, William S Cao, Lori Hillin, Benjamin J Haugo, Daniel R O' Brien, Jean-Pierre A Kocher, Robert A Kaiser, Joseph B Lillegard
Activation of homology-directed DNA repair plays key role in CRISPR-mediated genome correction. Gene therapy (2022)
Robert A Kaiser, Daniel F Carlson, Kari L Allen, Dennis A Webster, Caitlin J VanLith, Clara T Nicolas, Lori G Hillin, Yue Yu, Catherine W Kaiser, William R Wahoff, Raymond D Hickey, Adrienne L Watson, Shelley R Winn, Beat Thöny, Douglas R Kern, Cary O Harding, Joseph B Lillegard
Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing. PloS one 16 (1) (2021)
Whitney S Thompson, Gourish Mondal, Caitlin J Vanlith, Robert A Kaiser, Joseph B Lillegard
The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism. Expert opinion on orphan drugs 8 (7) (2020)

Joseph B Lillegard.css-eqlu8i{font-size:small;padding-left:4px;}